Urology · West Bloomfield, MI
NPI
1831171669
Since 2005
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6900 Orchard Lake Rd Ste 300
West Bloomfield, MI, 48322
Phone (248) 539-9036
Groups this clinician bills Medicare through
Medicare paid, 2024
$525K
15,405 services
Medicare patients, 2024
1,465
Average age 76
Drug cost, 2024
$2.5M
4,075 prescriptions
Company payments, 2025
$4,793
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian D Seifman was code J0897 (injection, denosumab, 1 mg), 3,840 times for 17 patients. In total Brian D Seifman billed 15,405 services in 131 codes, and Medicare paid $525K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,840 | 17 | $20.80 | $80K |
| 81003 Clinical Chemistry | Office | 1,919 | 1,170 | $2.18 | $4,192 |
| 99214 Office E&M - Established | Office | 1,480 | 1,021 | $94.51 | $140K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,294 | 940 | $12.64 | $16K |
| 51798 Ultrasound - Nonspecific | Office | 522 | 395 | $8.59 | $4,485 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 474 | 252 | $35.70 | $17K |
| 84153 Clinical Chemistry | Office | 446 | 350 | $18.02 | $8,037 |
| 99213 Office E&M - Established | Office | 234 | 213 | $68.47 | $16K |
| 52000 Cystourethroscopy | Office | 192 | 168 | $182.50 | $35K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 189 | 22 | $140.62 | $27K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 167 | 33 | $49.72 | $8,303 |
| 99204 Office E&M - New | Office | 123 | 123 | $120.69 | $15K |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 123 | 66 | $16.18 | $1,990 |
| 80048 Clinical Chemistry | Office | 118 | 93 | $8.29 | $978 |
| 84154 Clinical Chemistry | Office | 90 | 73 | $18.02 | $1,622 |
By year: 2022 $655K for 18,893 services; 2023 $487K for 12,624 services; 2024 $525K for 15,405 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,919 | 1,170 | $2.18 | $4,192 |
| 84153 Clinical Chemistry | 446 | 350 | $18.02 | $8,037 |
| 80048 Clinical Chemistry | 118 | 93 | $8.29 | $978 |
| 84154 Clinical Chemistry | 90 | 73 | $18.02 | $1,622 |
| 84403 Clinical Chemistry | 54 | 35 | $25.29 | $1,366 |
| 83735 Clinical Chemistry | 50 | 28 | $6.57 | $329 |
| 80076 Clinical Chemistry | 49 | 32 | $8.01 | $392 |
| 84100 Clinical Chemistry | 43 | 30 | $4.65 | $200 |
| 85025 Blood Count | 37 | 26 | $7.61 | $282 |
| 36415 Venipuncture Blood Collection | 34 | 32 | $8.65 | $294 |
Medicare prescription drug claims, 2024
In 2024, the drug Brian D Seifman prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,083 prescriptions and refills. In total Brian D Seifman wrote 4,075 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,083 | 3,000 | 375 | $23K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 477 | 1,313 | 163 | $16K |
| Finasteride Generic | 251 | 686 | 80 | $5,075 |
| Dutasteride Generic | 234 | 672 | 83 | $10K |
| Tolterodine Tartrate Er Tolterodine Tartrate | 210 | 556 | 79 | $24K |
| Myrbetriq Mirabegron | 157 | 340 | 66 | $145K |
| Xtandi Enzalutamide | 119 | 119 | 16 | $1.6M |
| Solifenacin Succinate Generic | 103 | 249 | 42 | $7,154 |
| Cephalexin Generic | 102 | 110 | 86 | $378 |
| Levofloxacin Generic | 91 | 91 | 80 | $134 |
| Trospium Chloride Er Trospium Chloride | 77 | 186 | 25 | $20K |
| Potassium Citrate Er Potassium Citrate | 73 | 184 | 26 | $6,728 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 70 | 200 | 24 | $2,394 |
| Abiraterone Acetate Generic | 68 | 68 | Under 11 | $175K |
| Testosterone Generic | 61 | 76 | Under 11 | $7,497 |
Brand drugs: 460 claims; generic drugs: 3,603 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian D Seifman $4,793 ($4,793 in general payments such as food, travel and fees) from 26 companies. The largest payer was Avyxa Pharma, LLC with $3,179.
| Company | Payments | Amount |
|---|---|---|
| Avyxa Pharma, LLC | 6 | $3,179 |
| Biotissue Holdings Inc. | 2 | $253 |
| Olympus America Inc. | 10 | $172 |
| Dendreon Pharmaceuticals LLC | 5 | $149 |
| Pfizer Inc. PFE | 6 | $135 |
| Astellas Pharma US Inc 4503.T | 4 | $86.24 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $83.11 |
| Verity Pharmaceuticals Inc. | 3 | $79.71 |
| Merck Sharp & Dohme LLC MRK | 3 | $71.94 |
| Immunitybio, Inc. IBRX | 3 | $70.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.